- ISIN
- US46138E7013
- CUSIP
- 73936Q629
- Sector
- Communication Services
- Industry
- Advertising Agencies
- IPO Date
- Jan 30, 2008
Highlights
- Market Cap
- $8.65K
- Enterprise Value
- -$3.88M
- Total Revenue (TTM)
- $81.32M
- Gross Profit (TTM)
- $3.68M
- EBITDA (TTM)
- $6.00M
- Year Range
- $0.15 - $285.44
- ROA (TTM)
- 25.01%
- ROE (TTM)
- 32.38%
- Avg. Volume (1M)
- 13M
- Avg. Volume Value (1M)
- $3.87M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
HAO Performance Chart
Haoxi Health Technology Limited (HAO) is down 99.9% since the beginning of the year. At $0 per share, HAO is trading 99.9% below its 52-week high of $285.
Loading charts...
Compare this symbol against anything
Returns By Period
Haoxi Health Technology Limited (HAO) has returned -99.89% so far this year and -99.91% over the past 12 months.
Haoxi Health Technology Limited
- 1D
- -1.73%
- 1M
- -85.95%
- 6M
- -99.92%
- YTD
- -99.89%
- 1Y
- -99.91%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -98.95%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
HAO Monthly Returns History
Based on dividend-adjusted daily data since Jan 26, 2024, HAO's average daily return is -0.98%, while the average monthly return is -14.87%.
Historically, 26% of months were positive and 74% were negative. The best month was Jan 2024 with a return of +80.0%, while the worst month was May 2026 at -98.9%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 7 months.
On a daily basis, HAO closed higher 43% of trading days. The best single day was Jan 30, 2024 with a return of +62.4%, while the worst single day was May 11, 2026 at -93.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 28.97% | -6.88% | -20.62% | -28.92% | -98.87% | -1.90% | -85.68% | -99.89% | |||||
| 2025 | -37.87% | -22.53% | -29.81% | 0.24% | 19.69% | -14.47% | 4.62% | -13.68% | 2.21% | -5.00% | -6.14% | -0.00% | -71.47% |
| 2024 | 80.00% | -5.88% | -15.83% | 21.12% | -1.23% | -26.34% | -21.35% | -20.95% | -89.15% | -42.10% | -37.17% | 14.50% | -96.47% |
Benchmark Metrics
Haoxi Health Technology Limited has an annualized alpha of -92.98%, beta of 0.99, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since January 26, 2024.
- This stock participated in 426.43% of S&P 500 Index downside but only -189.86% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -92.98%
- Beta
- 0.99
- R²
- 0.01
- Upside Capture
- -189.86%
- Downside Capture
- 426.43%
Return for Risk
Risk / Return Rank
HAO ranks 4 for risk / return — above 4% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Haoxi Health Technology Limited (HAO) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HAO | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.06 | ||
| Sortino ratioReturn per unit of downside risk | -4.88 | ||
| Omega ratioGain probability vs. loss probability | 0.51 | 1.25 | -0.74 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | 2.00 | -3.00 |
| Martin ratioReturn relative to average drawdown | -1.89 | 8.49 | -10.39 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Haoxi Health Technology Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Haoxi Health Technology Limited was 100.00%, occurring on Jul 31, 2026. The portfolio has not yet recovered.
The current Haoxi Health Technology Limited drawdown is 100.00%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-100.00%Jul 2026 | 2y 2mo | — | 2y 3moMay 2024 - now | — |
-49.18%Apr 2024 | 1mo 18d | 24d | 2mo 12dFeb 2024 - May 2024 | — |
-13.97%Feb 2024 | 2d | 13d | 15dJan 2024 - Feb 2024 | — |
-9.85%Jan 2024 | 1d | 1d | 1dJan 2024 - Jan 2024 | — |
Drawdown Indicators
| HAO | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -56.78% | -43.22% |
Max Drawdown (1Y)Largest decline over 1 year | -99.93% | -9.10% | -90.83% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -100.00% | -1.58% | -98.42% |
Average DrawdownAverage peak-to-trough decline | -82.27% | -10.70% | -71.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 52.77% | 2.14% | +50.63% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Haoxi Health Technology Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Haoxi Health Technology Limited is priced in the market compared to other companies in the Advertising Agencies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with HAO
Add Haoxi Health Technology Limited to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with HAO